Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients Clinical Trial

Official title: Evaluation of Cerebral Oxygen Saturation(rSO2) Measurements Between Frontal Lesion Area and Normal Area of Brain by Pulse Oximetry(NIRSITX) Using Near-infrared Spectroscopy in Acute Ischemic Stroke Patients, Prospective, Single-center, Non-randomized, Open-label, Exploratory Clinical Trial.

Status Not yet recruiting

Clinical Trial Summary

The clinical trial is for acute ischemic stroke patients measuring cerebral oxygen saturation (rSO2) values using pulse oximeter of near-infrared spectroscopy in the frontal lesion area and normal area of brain. The purpose of the clinical trial is to compare differences in cerebral oxygen saturation values, and the efficacy and safety are evaluated through additional exploratory clinical trials.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Acute Ischemic Stroke Patients
• Cerebral Infarction
• Ischemia
• Ischemic Stroke
• Stroke

• NCT number: NCT06250608
• Study type: Interventional
• Source: OBELAB, Inc.
• Contact: Tae Jung Kim
• Phone: 82-2-2072-1810
• Email: ttae35@gmail.com
• Status: Not yet recruiting
• Phase: N/A
• Start date: February 13, 2024
• Completion date: December 31, 2024